rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Daniel Bradbury

Director

Company insider

Files Form 4 as: Director, Vivani Medical; Director, Castle Biosciences; Chairman, Equillium; Director, Intercept Pharmaceuticals; Director, Nuvation Bio; Director, Geron; Director, Corcept Therapeutics; Director, Illumina.

In numbers

Trades disclosed
1,180
Buys
6
Sells
228
Bought
$1.2M
Sold
$182.7M
Companies
11
Companies where not an officer
9
First trade
5 Jan 2006
Last trade
27 Jul 2026
Last filed
28 Jul 2026

Companies traded

Where they are an officer
EQ EquilliumDirector, Officer, 10% owner · Biotechnology · last 28 May 20260 buys · 0 sells
Amylin PharmaceuticalsDirector, Officer · last 8 Aug 20120 buys · 24 sells
Everywhere else they filed: board seats, 10% stakes, other companies
VANI Vivani MedicalDirector · Medical Devices · last 27 Jul 20260 buys · 0 sells
CSTL Castle BiosciencesDirector · Diagnostics & Labs · last 28 May 20260 buys · 125 sells
Intercept PharmaceuticalsDirector · last 8 Nov 20231 buy · 0 sells
NUVB Nuvation BioDirector · Biotechnology · last 10 Feb 20210 buys · 0 sells
GERN GeronDirector · Biotechnology · last 29 Mar 20191 buy · 0 sells
CORT Corcept TherapeuticsDirector · Pharmaceuticals · last 7 Feb 20194 buys · 12 sells
ILMN IlluminaDirector · Life-science tools · last 25 May 20170 buys · 67 sells
BioMed Realty TrustDirector · last 27 Jan 20160 buys · 0 sells
NovaceaDirector · last 13 Feb 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Jul 2026filed 28 Jul 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$10K7,965 at $1.30filing
27 Jul 2026filed 28 Jul 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$10K7,965 at $1.30filing
24 Jun 2026filed 25 Jun 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$45K36,516 at $1.22filing
24 Jun 2026filed 25 Jun 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$45K36,516 at $1.22filing
28 May 2026filed 1 Jun 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—11,766 at $0.00filing
28 May 2026filed 1 Jun 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—11,766 at $0.00filing
28 May 2026filed 29 May 2026EQ Equilliumoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
28 May 2026filed 29 May 2026EQ Equilliumoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—13,667filing
22 May 2026filed 27 May 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,667 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,667 at $0.00filing
22 May 2026filed 27 May 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—13,667filing
1 Jan 2026filed 5 Jan 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$58K47,212 at $1.23filing
1 Jan 2026filed 5 Jan 2026VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$58K47,212 at $1.23filing
24 Jun 2025filed 26 Jun 2025VANI Vivani Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A$45K35,135 at $1.27filing
22 May 2025filed 23 May 2025CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—13,667 at $0.00filing
21 May 2025filed 23 May 2025CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—8,673 at $0.00filing
21 May 2025filed 23 May 2025CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M—8,673filing
14 Feb 2025filed 19 Feb 2025EQ Equilliumoption or derivative · BiotechnologySEC FORM 4 Code A—90,000filing
14 Feb 2025filed 19 Feb 2025EQ Equilliumoption or derivative · BiotechnologySEC FORM 4 Code D—90,000filing

The newest 500 lines are listed; the numbers count every line.

News

Sectors

Health Care209
Not placed25

Buys in green, sells in red, by the company’s sector.

Related people

Christine ZedelmayerSr. Vice President and COO · Sr. Vice President and COO at Equillium, filing Form 4 there in the last year
Stephen ConnellyPresident and CSO · President and CSO at Equillium, filing Form 4 there in the last year
Barbara TroupinDirector · Director at Equillium, filing Form 4 there in the last year
Charles Douglas McDermottDirector · Director at Equillium, filing Form 4 there in the last year
Penny TomPrincipal Accounting Officer · Principal Accounting Officer at Equillium, filing Form 4 there in the last year
James N. WilsonDirector · Also traded CORT in the last 90 days
Tobin W. JuvenalChief Commercial Officer · Also traded CSTL in the last 90 days
Derek J. MaetzoldPres. & Chief Exec. Officer · Also traded CSTL in the last 90 days